Clinical Trial Update: A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating chemoradiation plus pembrolizumab for locally advanced laryngeal squamous cell carcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Laryngeal Squamous Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Vinita Takiar | Conditions: Head and Neck Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-03-12